4-((Dimethylamino)methyl)thiazol-2-amine

Catalog No. :
ACZNGP475
CAS No. :
116252-53-0
Molecular Formula :
C6H11N3S
Molecular Weight :
157.24

IUPAC Name:4-((dimethylamino)methyl)thiazol-2-amine

4-((Dimethylamino)methyl)thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$187.00Login to see priceInquiryInquiry
100mg97%$270.00Login to see priceInquiryInquiry
250mg97%$381.00Login to see priceInquiryInquiry
1g97%$787.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((Dimethylamino)methyl)thiazol-2-amine
IUPAC Name4-((dimethylamino)methyl)thiazol-2-amine
MDL No.-
Molecular FormulaC6H11N3S
Molecular Weight157.24
SMILESNC1=NC(CN(C)C)=CS1
InChI KeyHYQAPLLDHDEUSD-UHFFFAOYSA-N
Synonym4-Thiazolemethanamine, 2-amino-N,N-dimethyl-;4-[(dimethylamino)methyl]-1,3-thiazol-2-amine;4-((dimethylamino)methyl)thiazol-2-amine
CAS No.116252-53-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZNGP475 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZNGP475 route product structure diagram
    ACZNGP475116252-53-0
Inquiry

2. ACZNGP475 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8 In Stock
  6. Then
  7. ACZNGP475 route product structure diagram
    ACZNGP475116252-53-0
Inquiry

Comments (0)